Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
38.99
-0.78 (-1.96%)
At close: Sep 21, 2026, 4:00 PM EDT
39.07
+0.08 (0.21%)
After-hours: Sep 21, 2026, 4:21 PM EDT
Roivant Sciences Employees
Roivant Sciences had 721 employees as of March 31, 2026. The number of employees decreased by 29 or -3.87% compared to the previous year.
Employees
721
Change (1Y)
-29
Growth (1Y)
-3.87%
Revenue / Employee
$10,447
Profits / Employee
-$369,283
Market Cap
28.16B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 721 | -29 | -3.87% |
| Mar 31, 2025 | 750 | -158 | -17.40% |
| Mar 31, 2024 | 908 | 4 | 0.44% |
| Mar 31, 2023 | 904 | 41 | 4.75% |
| Mar 31, 2022 | 863 | 198 | 29.77% |
| Jun 30, 2021 | 665 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Genmab | 3,119 |
| Jazz Pharmaceuticals | 2,890 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| Insmed | 1,664 |
| Ascendis Pharma | 1,189 |
ROIV News
- 5 days ago - Roivant Sciences initiated with a Buy at Stifel - TheFly
- 11 days ago - Roivant Sciences Transcript: Citigroup’s Biopharma Back to School Summit 2026 - Transcripts
- 12 days ago - Roivant Sciences Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 12 days ago - Roivant Sciences price target raised to $55 from $50 at TD Cowen - TheFly
- 12 days ago - Roivant Sciences price target raised to $46 from $42 at Guggenheim - TheFly
- 13 days ago - Roivant Sciences price target raised to $47 from $41 at H.C. Wainwright - TheFly
- 13 days ago - Roivant Sciences rises 18.9% - TheFly
- 13 days ago - Roivant Sciences price target raised to $52 from $42 at Jefferies - TheFly